| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/06/2014 | WO2014022740A1 Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles |
| 02/06/2014 | WO2014022639A1 Solid forms of (4-isopropoxy-3-methoxyphenyl)(2'-methyl-6'-(trifluoromethyl)-3',4'-dihydro-2'h-spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]-1-yl)methanone |
| 02/06/2014 | WO2014022390A1 Deuterated ibrutinib |
| 02/06/2014 | WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor |
| 02/06/2014 | WO2014020531A1 Imidazo[1,2-b]pyridazin-6-amine derivatives as kinase jak-2 inhibitors |
| 02/06/2014 | WO2014019908A2 Substituted pyrroles active as kinases inhibitors |
| 02/06/2014 | WO2014019468A1 Piperazinotrizole compound, preparation method therefor, and use thereof in drug preparation |
| 02/06/2014 | WO2013188539A3 Differential functionalization of polymers with aminooxy reagents |
| 02/06/2014 | US20140039215 4-Biphenyl-substituted pyrazolidin-3,5-dione derivatives |
| 02/06/2014 | US20140039186 Inhibitors of bruton's tyrosine kinase |
| 02/06/2014 | US20140039182 Compositions and processes of preparing and using the same |
| 02/06/2014 | US20140038989 Tetrahydropyrazolo [1,5-a] pyrimidine as anti-tuberculosis compounds |
| 02/06/2014 | US20140038988 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 02/06/2014 | US20140038981 Novel egfr modulators and uses thereof |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038969 Dihydropyridone p1 as factor xia inhibitors |
| 02/06/2014 | US20140038957 Ask 1 inhibiting pyrrolopyrimidine derivatives |
| 02/06/2014 | US20140038956 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc). |
| 02/06/2014 | US20140038953 Compositions and methods for cardiovascular disease |
| 02/06/2014 | US20140038946 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS |
| 02/06/2014 | US20140038941 Ring-fused heterocyclic derivative |
| 02/06/2014 | US20140038940 Novel egfr modulators and uses thereof |
| 02/06/2014 | US20140038939 Triazolopyridine jak inhibitor compounds and methods |
| 02/06/2014 | US20140038935 Dihydrodiazepines useful as inhibitors of protein kinases |
| 02/06/2014 | US20140037589 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 02/06/2014 | DE102013206380A1 Verbindung und diese umfassende organische lichtemittierende Vorrichtung Connection and this comprehensive organic light emitting device |
| 02/06/2014 | DE102012015148A1 Preparing dialkali metal phthalocyanine compounds useful as electrolytes in lithium ion batteries, comprises reacting phthalonitrile compounds with an alkali metal salt and a base |
| 02/05/2014 | EP2691398A1 Methods for synthesizing metal mesoporphyrins |
| 02/05/2014 | EP2691397A2 Methods and compositions for preparing noribogaine from voacangine |
| 02/05/2014 | EP2691396A2 Enopeptins, uses thereof, and methods of synthesis thereto |
| 02/05/2014 | EP2691395A1 Processes for preparing tofacitinib salts |
| 02/05/2014 | CN103562208A Tricyclic gyrase inhibitors |
| 02/05/2014 | CN103562206A 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
| 02/05/2014 | CN103562180A New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds |
| 02/05/2014 | CN103555322A Novel organic electroluminescent compounds and organic electroluminescent device using same |
| 02/05/2014 | CN103554116A Molecularly targeted anti-cancer photosensitizer tamoxifen-phthalocyanine conjugate and preparation method thereof |
| 02/05/2014 | CN103554115A Method for preparing protoporphyrin trimethyl ester |
| 02/05/2014 | CN103554114A Disubstituted pyrene diquinoxaline derivative, and preparation method and application thereof and electroluminescent device |
| 02/05/2014 | CN103554113A Method for synthesizing zilpaterol Hydrochloride |
| 02/05/2014 | CN103554112A Synthetic method of beta-lactam compound with cis condensed ring |
| 02/05/2014 | CN103554111A Aromatic heterocyclic pyridine derivatives and analogs, and preparation method and application thereof |
| 02/05/2014 | CN103554101A 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha7-nachr ligands for the treatment of cns diseases |
| 02/05/2014 | CN103554011A Anthracene containing derivative as well as preparation method and application thereof |
| 02/05/2014 | CN103549660A Filter additive capable of reducing hydrocyanic acid in cigarette smoke and preparing method thereof |
| 02/05/2014 | CN102690270B Pyrimidine compound and purpose thereof |
| 02/05/2014 | CN102558183B Pyrrolidine pyrazolyl oxo-quinoline carboxylic acid compound |
| 02/04/2014 | US8642779 Compositions useful as inhibitors of protein kinases |
| 02/04/2014 | US8642638 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
| 02/04/2014 | US8642610 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters |
| 02/04/2014 | US8642607 4H-chromen-4-one compounds as modulators of protein kinases |
| 02/04/2014 | US8642606 ZAP-70 active compounds |
| 02/04/2014 | US8642605 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines |
| 02/04/2014 | US8642604 Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents |
| 02/04/2014 | US8642601 Inhibitors of JNK |
| 02/04/2014 | US8642594 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors |
| 02/04/2014 | US8642590 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
| 02/04/2014 | US8642281 Coelenterazine analogues and coelenteramide analogues |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 01/30/2014 | WO2014018925A1 Compositions and methods for treating microbial infections |
| 01/30/2014 | WO2014018873A2 Compositions comprising folic acid derivatives. their preparations and methods of use |
| 01/30/2014 | WO2014018355A1 Treating diabetes with dipeptidyl peptidase-iv inhibitors |
| 01/30/2014 | WO2014018350A1 Treating diabetes with dipeptidyl peptidase-iv inhibitors |
| 01/30/2014 | WO2014017659A1 Agent for treating or controlling recurrence of acute myelogenous leukemia |
| 01/30/2014 | WO2014016789A1 Pyrazolo[3,4-d]pyrimidin-4(5h)-one derivatives as pde9 inhibitors |
| 01/30/2014 | WO2014015830A1 Novel heteroaryl and heterocycle compounds, composition and methods thereof |
| 01/30/2014 | WO2014015673A1 4-position substituted pyrazolopyrimidine derivative, and use thereof in drug preparation |
| 01/30/2014 | WO2013083611A3 Ring-bridged anthraquinone dye for dyeing keratinous fibres |
| 01/30/2014 | US20140031358 Quinazolinediones and their use |
| 01/30/2014 | US20140031357 Asymmetrically substituted anthrapyridazone derivatives as cytostatics |
| 01/30/2014 | US20140031354 Protein Kinase Inhibitors |
| 01/30/2014 | US20140031351 Macrocyclic Compounds as ALK, FAK and JAK2 Inhibitors |
| 01/30/2014 | US20140031339 Inhibitors of leukotriene production |
| 01/30/2014 | US20140031337 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 01/30/2014 | US20140031334 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 01/30/2014 | US20140031330 ARYL SULTAM DERIVATIVES AS RORc MODULATORS |
| 01/30/2014 | US20140031206 Substituted pyrimidinium compounds for combating animal pests |
| 01/30/2014 | US20140030256 Benzoxazole kinase inhibitors and methods of use |
| 01/29/2014 | EP2690101A1 5-Anilinoimidazopyridines and Methods of Use |
| 01/29/2014 | EP2689780A1 Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group |
| 01/29/2014 | EP2688890A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 01/29/2014 | EP2688889A1 4h-imidazo[1,2-a]imidazoles for electronic applications |
| 01/29/2014 | EP2688888A1 Process for the production of a pemetrexed salt |
| 01/29/2014 | EP2688886A1 Azole compounds as pim inhibitors |
| 01/29/2014 | EP2688872A1 Amidopyrazole inhibitors of interleukin receptor-associated kinases |
| 01/29/2014 | EP2435435B1 Pyrimidine inhibitors of kinase activity |
| 01/29/2014 | EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN103547580A Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 01/29/2014 | CN103547579A Fused imidazole derivatives useful as ido inhibitors |
| 01/29/2014 | CN103547568A Resin-transfer-moldable terminal-modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether and having excellent moldability, mixture thereof, varnish containing same, and cured resin thereof and fiber-reinforced cured resin thereof made by re |
| 01/29/2014 | CN103539800A Preparation method of large-particle hexanitrohexaazaisowurtzitane explosive |
| 01/29/2014 | CN103539799A Preparation method and application of water-soluble aminopolycarboxylic acid modified phthalocyanine compound |
| 01/29/2014 | CN103539798A Synthetic method of bicyclo-guanidine (1, 5, 7-triaza-bicyclo [5. 5. 0] deca-5-ene) |
| 01/29/2014 | CN103539797A Novel compounds of reverse turn mimetics and the use thereof |
| 01/29/2014 | CN103539784A Heterocyclic benzamide compounds, pharmaceutical compositions as well as application thereof |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |
| 01/29/2014 | CN102267993B Polyhydroxy desmethyl tropane compounds and preparation method and use thereof |
| 01/29/2014 | CN101801958B Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2014 | CN101479252B Methods for the preparation of pyrazole-containing compounds |